Abstract
Early recognition and treatment of PTSD can improve the functional outcomes and prognosis for children and adolescents. Psychotherapeutic interventions are considered the first-line options for youth struggling with PTSD. However, pharmacological agents now are being used in this population, with evidence mostly inferred from adult literature. Hence, it is important to review existing evidence for the use of pharmacological agents in the pediatric population with PTSD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
